August 2018 FDA Recall Drug by Mckesson Corporation
D-1172-2018 - Supterpotent Drug

This Class II drug recall was voluntarily initiated by Mckesson Corporation on August 14, 2018 for the product Drug. The FDA reported the reason for recall as supterpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1172-2018

Reason for Recall
Supterpotent Drug
Initiated
08-14-2018
Reported
09-12-2018
Quantity
1531 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Mckesson Corporation
Nationwide within the United States
Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977 Dist. By: McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51

Batch or Lot Expiration Information

Lot# : 0116158 Exp. 4/30/19; 0113903, 0113902, 0113901, Exp. 8/31/18